Deal snapshot: ConMed to Acquire Biorez for USD 85m in Cash.

MANews-(C)2009-2022

US-based medical technology company ConMed Corp. (NYSE: CNMD) has inked a definitive agreement to acquire US-based medical device start-up Biorez, Inc for cash consideration of USD 85m at closing, the company said.

Consideration will include up to an additional USD 165m in growth-based earnout payments over a four-year period. The...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT